Publications

Find coverage of the latest original articles on Lupus, focusing on those with data on therapeutic interventions and those that have clinical impact.

This activity is supported by an educational grant from AstraZeneca.

Anifrolumab, Mycophenolate mofetil, Sm-Tregs, CAR T-Cell, CV Risk factors,

September 2022

$Publication thumbnail: Anifrolumab for Treatment of Refractory Cutaneous Lupus Erythematosus$ View Slides

Clin Exp Dermatol. 2022. Epub ahead of print doi:10.1111/ced.15335

First report of multiple cases of successful Cutaneous Lupus Erythematosus (CLE) treatment in active smokers with anifrolumab.